RE: tborOk, tbor, Oppenheimer bought the financing. To whom are they selling it? Is it 1 name or 2 names, corporate, private? What if it's a cheap and undisclosed way for a pharma to buy the stock, a way that's even unknown to Oppenheimer? Or is it a way for RVX to put shares in the hands of special friends? Or does RVX really need the money? I don't know but I suspect they need the money. It may even be used to cash up the RVX Therapeutics spinoff if that's what it takes to get the job done. However, I doubt the spinoff scenario because the spinoff contains NexVas for Alzheimer's although it could be "sold" back to RVX for a big portion of the financing. I would expect all of the NexVas parts will be sold together in RVX for reasons discussed here before.
And why not just get a loan as you suggest? Because who in his right mind would play for a 6 or 8 (or 15) percent rate of return when they can have the rate plus conversion privileges! Who would loan money to a company with no revenue but with high value appreciation prospects? Nobody, that's who! My goodness, they can even convert the interest to stock and they can short the stock and cover with the conversion stock. I wouldn't loan RVX a nickle, nor would anybody else in his right mind.